Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.2 USD | -0.78% | +2.59% | +19.46% |
04:14pm | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
08:52am | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.46% | 332B | |
+26.01% | 661B | |
+26.74% | 566B | |
-6.72% | 352B | |
+3.46% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.29% | 145B | |
-10.61% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck, Daiichi Sankyo Dose First Person in Phase 2/3 Trial of Raludotatug Deruxtecan to Treat Ovarian Cancer